HOXA-AS3 and central nervous system cancer: For example, suppression of HOXA-AS3 in glioma tumor models showed an apparent reduction in glioma tumor weight and size, suggesting the promising therapeutic potential of targeted-HOXA‐AS3 for glioma [27].